세계의 안과의료기기 시장 : 규모, 점유율, 동향 분석(제품별, 용도별, 최종 용도별, 지역별), 부문별 예측(2025-2030년)

Ophthalmic Devices Market Size, Share & Trends Analysis Report By Product (Optical Coherence Tomography, Ophthalmic Ultrasound), By Application (Cataract, Glaucoma), By End Use (Hospitals, Eye Clinics) And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,158,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,529,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,271,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

안과의료기기 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 안과의료기기 시장 규모는 2025년부터 2030년까지 연평균 복합 성장률(CAGR) 7.7%로 성장할 것으로 예상되며, 2030년에는 298억 달러에 이를 것으로 추정됩니다.

노년 인구 증가는 만성적인 눈 장애의 발병 위험이 높기 때문에 안과 의료기기의 요구를 촉진한다고 추측되고 있습니다. 병성 망막증, 녹내장 등 눈 질환의 유병률 상승도 제품 수요를 끌어 올리고 있습니다. 녹내장은 세계에서 450만 건의 실명을 일으키고 있습니다.

시장 성장은 안구내 렌즈, 안저카메라, OCT 장치 개발 등의 기술적 진보에도 기인하고 있습니다. 또한 전략적 제휴를 통해 치료 솔루션의 확대에 임하는 시장 기업 증가도 이 시장에 잠재적인 성장 기반을 가져올 것으로 예측됩니다. WHO 통계에 따르면 안과 질환을 앓고 있는 사람들의 약 10%가 적절한 치료에도 불구하고 시력을 잃을 것으로 예상되어, 고도로 발전된 안과 의료기기를 도입해야 하는 시급성이 커지고 있습니다. 또한, 저침습으로 합병증이 없는 수술에 대한 수요 증가가 제품 수요를 끌어 올릴 것으로 예상되고 있습니다.

안과의료기기 시장 : 분석 개요

• 제품별로는 광간섭 단층계(OCT) 분야가 시장을 독점해, 2024년에는 23.3%의 최대 매출 점유율을 차지했습니다.
• 백내장 분야가 시장을 독점해 2024년에는 41.5%의 최대 수익 점유율을 차지했습니다.
• 검안경 부문은 예측 기간 중에 8.1%의 대폭적인 성장률이 예상되고 있습니다.
• 백내장 분야는 시장을 독점해, 2024년에는 41.5%의 최대 수익 점유율을 차지했습니다.
• 이 성장은 백내장을 앓는 환자 수 증가와 백내장 수술에 대한 높은 제품 채용률에 기인하고 있습니다.

목차

제1장 분석 방법 및 범위

제2장 주요 요약

제3장 안과의료기기 시장 : 변동 요인, 경향, 범위

• 시장 연관 전망
  • 부수 시장 전망
• 가격 분석
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회의 분석
• 안과의료기기 시장 : 분석 도구
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 안과의료기기 시장 : 제품별 추정 및 동향 분석

• 부문 대시보드
• 안과의료기기 시장 : 제품별 변동 분석
• 안과의료기기 시장 전망 : 제품별
• 시장 규모 예측과 동향 분석(2018-2030년)
• 광간섭 단층촬영(OCT)
• 안저 카메라
• 시야계, 시야 분석 장치
• 오토레프랙트미터 및 케라토미터
• 안과용 초음파 영상 시스템
  • 안과 A 스캔 초음파
  • 안과 B 스캔 초음파
  • 안과용 초음파 생체 현미경
• 안과용 파키미터
• 안압계
• 슬릿 램프
• 팔롭터
• 파면 수차계
• 광학 생체 측정 시스템
• 검안경
• 렌즈 미터
• 각막 토포그래피 시스템
• 스페큘러 현미경
• 망막 거울

제5장 안과의료기기 시장 : 용도별 추정 및 동향 분석

• 부문 대시보드
• 안과의료기기 시장 : 용도별 변동 분석
• 안과의료기기 시장 전망 : 용도별
• 시장 규모 예측과 동향 분석(2018-2030년)
• 백내장
  • 유리체 망막 질환
  • 녹내장
  • 굴절 이상

제6장 안과의료기기 시장 : 최종 용도별 추정 및 동향 분석

• 부문 대시보드
• 안과의료기기 시장 : 최종 용도별 변동 분석
• 안과의료기기 시장 전망 : 최종 용도별
• 시장 규모 예측과 동향 분석(2018-2030년)
• 병원, 안과의원
• 학술연구실
• 기타

제7장 안과의료기기 시장 : 지역별 추정 및 동향 분석

• 지역 대시보드
• 안과의료기기 시장 : 지역 갈등의 변동 분석
• 안과의료기기 시장 전망 : 지역별(제품별, 최종 용도별)
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 시장 진출기업의 분류
• 주요 기업 프로파일
• 시장 점유율과 포지션 분석(2024년)
  • Johnson & Johnson Vision Care
  • Alcon Vision LLC
  • Carl Zeiss Meditec AG
  • Bausch & Lomb Incorporated
  • Essilor International S.A
  • Ziemer Ophthalmic Systems Ltd
  • Nidek Co.
  • TOPCON CORPORATION
  • Haag-Streit Group
  • Glaukos Corporation

SHW

영문 목차

영문목차

Ophthalmic Devices Market Growth & Trends:

The global ophthalmic devices market size is estimated to reach USD 29.80 billion by 2030, expanding at a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising geriatric population is presumed to propel the need for ophthalmic devices due to the high risk of developing chronic eye disorders. According to the National Institute on Aging (NIA), the geriatric population will be about 72 million individuals by 2030. The rising prevalence of eye disorders, such as macular degeneration, cataracts, diabetic retinopathy, and glaucoma, is also boosting product demand. As per the WHO, glaucoma accounts for 4.5 million cases of blindness globally. In the United States, glaucoma is termed the "Silent Thief of Sight," which is the second-leading cause of blindness.

The market growth can also be attributed to technological advancements, such as the development of intraocular lenses, fundus cameras, and OCT devices. Furthermore, the increasing involvement of market players in expanding treatment solutions through strategic alliances is expected to present this market with a potential growth platform. Approximately 10% of the people suffering from eye disorders are expected to experience loss of vision despite the proper treatment, as per the statistics of the WHO, driving the clinical urgency to incorporate highly advanced ophthalmic devices. Furthermore, rising demand for minimally invasive and complication-free operative surgeries is expected to boost product demand. Due to the COVID-19 pandemic, the majority of the population's screen time was increased, resulting in increased cases of various eye issues, which will support market growth over the forecast period.

Ophthalmic Devices Market Report Highlights:

• Based on product, The optical coherence tomography (OCT) segment dominated the market and accounted for the largest revenue share of 23.3% in 2024.
• The cataract segment dominated the market and accounted for the largest revenue share of 41.5% in 2024.
• The ophthalmoscopes segment is anticipated to witness a significant growth rate of 8.1% over the forecast period.
• The cataract segment dominated the market and accounted for the largest revenue share of 41.5% in 2024.
• This growth can be attributed to the increasing number of patients suffering from cataracts and high product adoption for cataract surgeries

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Ophthalmic Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Pricing Analysis
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising prevalence of eye disease
    • 3.3.1.2. Technological advancements in ophthalmic surgical and diagnostic instruments
    • 3.3.1.3. Government initiatives for increasing awareness related to visual impairment
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Lack of trained ophthalmologists in developing nations
    • 3.3.2.2. High cost of devices in developing economies
  • 3.3.3. Market Challenge Analysis
• 3.4. Ophthalmic Devices Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Bargaining power of suppliers
    • 3.4.1.2. Bargaining power of buyers
    • 3.4.1.3. Threat of substitutes
    • 3.4.1.4. Threat of new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political & Legal Landscape
    • 3.4.2.2. Economic and Social Landscape
    • 3.4.2.3. Technological landscape

Chapter 4. Ophthalmic Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Ophthalmic Devices Market: Product Movement Analysis
• 4.3. Ophthalmic Devices Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Optical Coherence Tomography (OCT)
  • 4.5.1. Optical Coherence Tomography (OCT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Fundus Camera
  • 4.6.1. Fundus Camera Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Perimeters/Visual Field Analyzers
  • 4.7.1. Perimeters/Visual Field Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Autorefractors and Keratometers
  • 4.8.1. Autorefractors and Keratometers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Ophthalmic Ultrasound Imaging Systems
  • 4.9.1. Ophthalmic Ultrasound Imaging Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9.2. Ophthalmic A-Scan Ultrasound
    • 4.9.2.1. Ophthalmic A-Scan Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9.3. Ophthalmic B-Scan Ultrasound
    • 4.9.3.1. Ophthalmic B-Scan Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9.4. Ophthalmic Ultrasound Biomicroscopes
    • 4.9.4.1. Ophthalmic Ultrasound Biomicroscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.10. Ophthalmic Pachymeters
  • 4.10.1. Ophthalmic Pachymeters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.11. Tonometers
  • 4.11.1. Tonometers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.12. Slit Lamps
  • 4.12.1. Slit Lamps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.13. Phoropters
  • 4.13.1. Phoropters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.14. Wavefront Aberrometers
  • 4.14.1. Wavefront Aberrometers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.15. Optical Biometry Systems
  • 4.15.1. Optical Biometry Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.16. Ophthalmoscopes
  • 4.16.1. Ophthalmoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.17. Lensometers
  • 4.17.1. Lensometers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.18. Corneal Topography Systems
  • 4.18.1. Corneal Topography Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.19. Specular Microscopes
  • 4.19.1. Specular Microscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.20. Retinoscopes
  • 4.20.1. Retinoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Ophthalmic Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Ophthalmic Devices Market: Application Movement Analysis
• 5.3. Ophthalmic Devices Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Cataract
  • 5.5.1. Cataract Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Vitreo Retinal Disorders
    • 5.5.2.1. Vitreo Retinal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Glaucoma
    • 5.5.3.1. Glaucoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. Refractive Disorders
    • 5.5.4.1. Refractive Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Ophthalmic Devices Market: End use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Ophthalmic Devices Market: End use Movement Analysis
• 6.3. Ophthalmic Devices Market by End use Outlook (Revenue, USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals and Eye Clinics
  • 6.5.1. Hospitals and Eye Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Academic and Research Laboratory
  • 6.6.1. Academic and Research Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Ophthalmic Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Ophthalmic Devices Market: Regional Movement Analysis
• 7.3. Ophthalmic Devices Market: Regional Estimates & Trend Analysis by Product & End use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement Scenario
    • 7.5.2.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement Scenario
    • 7.5.3.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement Scenario
    • 7.5.4.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement Scenario
    • 7.6.2.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement Scenario
    • 7.6.3.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement Scenario
    • 7.6.4.5. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement Scenario
    • 7.6.5.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement Scenario
    • 7.6.6.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement Scenario
    • 7.6.7.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement Scenario
    • 7.6.8.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement Scenario
    • 7.6.9.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement Scenario
    • 7.7.2.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement Scenario
    • 7.7.3.5. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement Scenario
    • 7.7.4.5. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement Scenario
    • 7.7.5.5. South Korean market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement Scenario
    • 7.7.6.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement Scenario
    • 7.7.7.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement Scenario
    • 7.8.2.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement Scenario
    • 7.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement Scenario
    • 7.9.2.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement Scenario
    • 7.9.3.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement Scenario
    • 7.9.4.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement Scenario
    • 7.9.5.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
• 8.3. Market Share & Position Analysis, 2024
  • 8.3.1. Johnson & Johnson Vision Care
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Alcon Vision LLC
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Carl Zeiss Meditec AG
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Bausch & Lomb Incorporated
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Essilor International S.A
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Ziemer Ophthalmic Systems Ltd
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Nidek Co. Ltd.
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. TOPCON CORPORATION
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Haag-Streit Group
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Glaukos Corporation
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives

관련자료